• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术治疗胰导管腺癌:从动脉优先方法到三角形手术。

Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma: from Artery-First Approaches toTRIANGLE Operation.

出版信息

Chirurgia (Bucur). 2022 Jun;117(4):377-384. doi: 10.21614/chirurgia.2771.

DOI:10.21614/chirurgia.2771
PMID:36049094
Abstract

Pancreatico-duodenectomy (PD) is the single hope for long-term survival in a patient with pancreatic head ductal adenocarcinoma (PDAC). Unfortunately, even after curative intent PD, the long-term survival of patients with PDAC remains under expectations, with high recurrence rates, including the loco-regional ones. Positive resection margins after resection of PDAC are frequent, and they have a detrimental effect on both recurrence and long-term survival rates, particularly the R1 (direct) ones, toward the mesopancreas. In the last years, there were made increased efforts by surgeons to introduce in clinical practice several technical refinements to the standard technique of PD better to resect the tumor, including an accurate lymph node dissection, hoping to increase the rate of negative resection margins, to decrease local recurrence rates and to improve prognosis. Furthermore, to extend the number of patients with resectable disease, a few surgical techniques were also intended to convert to resectability the patients with the regional disease (i.e., anatomical borderline resectable and locally advanced PDAC) in the context of multimodal therapies, particularly neoadjuvant therapies. With this, we briefly discuss a few technical refinements addressing the resection time of PD, like the artery-first approaches and the Triangle operation. Both surgical techniques aim for better clearance of the retroperitoneal space for nerves, lymphatic nodes, and vessels, including total mesopancreas excision.

摘要

胰十二指肠切除术(PD)是胰腺头部导管腺癌(PDAC)患者长期生存的唯一希望。不幸的是,即使在有治愈意图的 PD 之后,PDAC 患者的长期生存率仍低于预期,复发率较高,包括局部复发。PDAC 切除后的阳性切缘很常见,这对复发和长期生存率都有不利影响,特别是朝向中肠系膜的 R1(直接)切缘。近年来,外科医生做出了更多努力,将几种技术改进引入 PD 的标准技术中,以更好地切除肿瘤,包括准确的淋巴结清扫,希望提高阴性切缘率,降低局部复发率,并改善预后。此外,为了扩大可切除疾病患者的数量,一些外科技术也旨在将区域疾病(即解剖边界可切除和局部进展期 PDAC)患者转化为可切除性,在多模态治疗,特别是新辅助治疗的背景下。为此,我们简要讨论了一些针对 PD 切除时间的技术改进,如动脉优先方法和三角操作。这两种手术技术都旨在更好地清除腹膜后空间的神经、淋巴结和血管,包括全中肠系膜切除。

相似文献

1
Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma: from Artery-First Approaches toTRIANGLE Operation.胰十二指肠切除术治疗胰导管腺癌:从动脉优先方法到三角形手术。
Chirurgia (Bucur). 2022 Jun;117(4):377-384. doi: 10.21614/chirurgia.2771.
2
What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature.全胰系膜切除术在胰腺导管腺癌中的价值是什么?文献的当前证据。
Chirurgia (Bucur). 2018 May-Jun;113(3):335-343. doi: 10.21614/chirurgia.113.3.335.
3
MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.MAPLE-PD试验(胰十二指肠切除术中胰腺癌的肠系膜入路与传统入路对比):一项针对354例胰腺导管腺癌患者的多中心随机对照试验的研究方案
Trials. 2018 Nov 8;19(1):613. doi: 10.1186/s13063-018-3002-z.
4
Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.标准定义切缘后胰十二指肠切除术治疗胰导管腺癌的胰切缘状态的前瞻性评估。
Pancreatology. 2020 Apr;20(3):537-544. doi: 10.1016/j.pan.2020.01.004. Epub 2020 Jan 10.
5
Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.标准化组织病理学方案对胰十二指肠切除术治疗胰腺导管腺癌患者 R1 切缘阳性率的长期生存影响。
Chirurgia (Bucur). 2024 Apr;119(2):171-183. doi: 10.21614/chirurgia.2024.v.119.i.2.p.171.
6
Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.胰头导管腺癌伴门静脉肠系膜静脉侵犯整块切除术的长期结果。
Asian J Surg. 2021 Jan;44(1):313-320. doi: 10.1016/j.asjsur.2020.07.021. Epub 2020 Sep 21.
7
Surgical treatment of pancreatic cancer.胰腺癌的外科治疗
Pol Przegl Chir. 2018 Apr 30;90(2):45-53. doi: 10.5604/01.3001.0011.7493.
8
Left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma.采用左后入路行胰十二指肠切除术,同时行全胰系膜切除及肠系膜上动脉周围环状淋巴结清扫术治疗胰头癌。
J Nippon Med Sch. 2013;80(6):438-45. doi: 10.1272/jnms.80.438.
9
The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.胰腺内肿瘤位置对胰腺导管腺癌切除术后生存的预后影响。
BMC Surg. 2015 Nov 28;15:123. doi: 10.1186/s12893-015-0110-5.
10
Current Surgical Concepts and Future Perspectives in the Treatment of Borderline Resectable and Potentially Resectable Locally Advanced Pancreatic Cancer.目前在边缘可切除和潜在可切除局部进展期胰腺癌治疗中的外科新概念和未来展望。
Chirurgia (Bucur). 2022 Jun;117(4):385-398. doi: 10.21614/chirurgia.2770.

引用本文的文献

1
Prognostic value of peripheral blood fibrinogen-to-albumin ratio and neutrophil-to-lymphocyte ratio in patients with locally advanced or metastatic pancreatic cancer.外周血纤维蛋白原与白蛋白比值及中性粒细胞与淋巴细胞比值在局部晚期或转移性胰腺癌患者中的预后价值
Am J Transl Res. 2024 Nov 15;16(11):7165-7175. doi: 10.62347/ZOHP7650. eCollection 2024.